These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 5770018)

  • 21. Brain acyl-coenzyme A hydrolase: distribution, purification and properties.
    Anderson AD; Erwin VG
    J Neurochem; 1971 Jul; 18(7):1179-86. PubMed ID: 4940817
    [No Abstract]   [Full Text] [Related]  

  • 22. [On the effect of various digitalis substances on monoamine oxidase activity in rat, guinea pig and cat brain].
    Popov N; Förster W
    Acta Biol Med Ger; 1966; 17(2):221-31. PubMed ID: 5983237
    [No Abstract]   [Full Text] [Related]  

  • 23. Distribution and inhibition characteristics of human brain monoamine oxidase.
    Owen F; Cross AJ; Lofthouse R; Glover V
    Biochem Pharmacol; 1979 Apr; 28(7):1077-80. PubMed ID: 444264
    [No Abstract]   [Full Text] [Related]  

  • 24. Letter: Monoamine tetrazolium reductase of rat heart mitochondria.
    Sen R; Parmar SS; Guha SR
    J Pharm Pharmacol; 1973 Oct; 25(10):835-7. PubMed ID: 4149751
    [No Abstract]   [Full Text] [Related]  

  • 25. Effect of oxygen tension on monoamine oxidase activity.
    Novick WJ
    Biochem Pharmacol; 1966 Aug; 15(8):1009-12. PubMed ID: 5973150
    [No Abstract]   [Full Text] [Related]  

  • 26. [INHIBITION OF RAT BRAIN MONOAMINE OXIDASES BY BETA-PHENYLISOPROPYLHYDRAZINE AND HARMALINE: HISTOCHEMICAL STUDY OF THE ACTION OF THESE INHIBITORS AND THEIR ANTAGONISM].
    BOUCHAUD C; COUTEAUX R; GAUTRON J
    C R Hebd Seances Acad Sci; 1965 Jan; 260():348-51. PubMed ID: 14305447
    [No Abstract]   [Full Text] [Related]  

  • 27. Multiple binding sites of human brain and liver monoamine oxidase: substrate specificities, selective inhibitions, and attempts to separate enzyme forms.
    White HL; Glassman AT
    J Neurochem; 1977 Dec; 29(6):987-97. PubMed ID: 599351
    [No Abstract]   [Full Text] [Related]  

  • 28. Inhibition patterns of monoamine oxidase in sub-fractions of rat brain mitochondria in presence of some selective inhibitors.
    Mitra C; Guha SR
    Biochem Pharmacol; 1979 Apr; 28(7):1135-7. PubMed ID: 444271
    [No Abstract]   [Full Text] [Related]  

  • 29. Monoamine oxidase activities in neuronal and glial fractions from regional areas of rat brain.
    Hazama H; Ito M; Hirano M; Uchimura H
    J Neurochem; 1976 Feb; 26(2):417-9. PubMed ID: 1255204
    [No Abstract]   [Full Text] [Related]  

  • 30. [Importance of the initial monoamine oxidase activity for the development of the activating or inhibiting action of indolylhydrazides].
    Safrazbekian RR; Sukasian RS; Arzanunts EM
    Vopr Med Khim; 1979; 25(3):311-4. PubMed ID: 452498
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Monoamine oxidase in man: enzyme characteristics in platelets, plasma, and other human tissues.
    Murphy DL; Donnelly CH
    Adv Biochem Psychopharmacol; 1974; 12(0):71-85. PubMed ID: 4607554
    [No Abstract]   [Full Text] [Related]  

  • 32. Procaine HCl (Gerovital H3): a weak, reversible, fully competitive inhibitor of monoamine oxidase.
    MacFarlane MD
    Fed Proc; 1975 Jan; 34(1):108-10. PubMed ID: 1109354
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Synthesis of some N-substituted eleostearic acid hydrazides as potential monoamine oxidase inhibitors.
    Hsu SY; Huang CL; Waters IW
    J Med Chem; 1973 May; 16(5):450-2. PubMed ID: 4146252
    [No Abstract]   [Full Text] [Related]  

  • 34. Effect of iproniazid on excretion of aromatic amines in x-irradiated rats.
    Nadkarni GB; Raghavan KG
    Int J Radiat Biol Relat Stud Phys Chem Med; 1970; 18(1):95-8. PubMed ID: 5311618
    [No Abstract]   [Full Text] [Related]  

  • 35. Studies on the selective inhibition of membrane-bound rat liver monoamine oxidase.
    Mantle TJ; Wilson K; Long RF
    Biochem Pharmacol; 1975 Nov; 24(22):2031-8. PubMed ID: 1212252
    [No Abstract]   [Full Text] [Related]  

  • 36. Evidence for a specific monoamine oxidase associated with sympathetic nerves.
    Goridis C; Neff NH
    Neuropharmacology; 1971 Sep; 10(5):557-64. PubMed ID: 5126693
    [No Abstract]   [Full Text] [Related]  

  • 37. Regional distribution of tyrosine hydroxylase in rat brain.
    Cicero TJ; Sharpe LG; Robins E; Grote SS
    J Neurochem; 1972 Sep; 19(9):2241-3. PubMed ID: 4403688
    [No Abstract]   [Full Text] [Related]  

  • 38. Inhibition of monoamine oxidase activity by antidepressants and mood stabilizers.
    Fisar Z; Hroudová J; Raboch J
    Neuro Endocrinol Lett; 2010; 31(5):645-56. PubMed ID: 21200377
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Relationship between the action of monoamine oxidase inhibitors on the noradrenaline uptake system and their antidepressant efficacy.
    Hendley ED; Snyder SH
    Nature; 1968 Dec; 220(5174):1330-1. PubMed ID: 5701350
    [No Abstract]   [Full Text] [Related]  

  • 40. Inhibition of monoamine oxidation in brain by monoamine oxidase inhibitors.
    Guha SR; Ghosh SK
    Biochem Pharmacol; 1970 Nov; 19(11):2929-32. PubMed ID: 5512700
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.